Antibiotics Flashcards
Beta-lactams
Penicillins (natural, antistaphylococcal, extended-spec, and antipseudomonal)
Cephalosporins (1-5)
Carbapenems
Monobactams
Cell-wall synthesis inhibitors
beta-lactams (PBPs = no synthesis of stable cell wall), vanco (transglycosylase = prevent binding of peptidoglycans, bacitracin (interferes with transport across cell)
Bactericidal, time-dependent
Cell membrane disruption
polymyxin, daptomycin
Classes that inhibit protein synthesis
Tetracyclines (30S), macrolides (50S), and aminoglycosides (30S - bactericidal)
Classes that inhibit nucleic acid synthesis
RNA polymerase inhibitor - rifampin
DNA replication inhibitor - Fluoroquniolones (cirpfloxacin)
Classes that inhibit folic acid synthesis
Trimethoprim and sulfonamides (sulfamethoxazole)
Streptococcus treatments
Penicillin V
Amoxicillin
Cephalexin
Amoxicillin+clavulanic acid
Allergy to beta-lactam: azithromycin, clarithromycin, clindamycin
MSSA treatments
Nafcillin Oxacillin Dicloxacillin Cephalexin Amoxicillin+clauvulanic acid 3rd gen cephalosporins for severe infections
Allergy to beta-lactams: azithromycin, clarithromycin, clindamycin
MRSA treatments
Ceftaroline (moderate) Vanco (severe) Dapto (severe) SMX/TMP (mild-moderate) Doxy (moderate) Minocycline (moderate) Clindamycin (moderate) Linezolid (severe)
Extended spectrum penicillins treat these gram-
Haemophilus influenzae Heliobacter pylori Escherichia coli Listeria monocytogenes Proteus mirabilis Salmonells Shigells Enterococci (HHELPSSE)
Superinfection
- Broad-spectrum antibiotics (frequent: extended-spec penicillins, cephalosporins, clindamycin, fluoroquinolones; occasionally: TMP/SMX, macrolides)
- organisms: Clostridium difficile (pseudomembranous colitis), Staphylococcus aureus (entercolitis), candida albicans (vagina and mouth infections)
Activity of cephalosporins moving from 1st to 4th gen
Increasing activity against g-, beta-lactamase, pseudomonas, anaerboes; increasing ability to cross BBB
1st gen cephalosporins
- Cephalexin, cefazolin
- g+ (staph and strep, PEcK - proteus mirabilis, E.coli, and Klebsiella pneumoniae
- UTI
- SSTI caused by staph and strep like cellulitis or abscess
Vancomycin use
MRSA, Enterocolitis, C. diff, enterococci
Vanco adverse effects
Nephrotoxicity
Ototoxicity
Thrombophlebitis
Red man syndrome - histamine release (pre-treat with anti-histamine and slow infusion rate)
Vanco resistance
D-ala-D-ala to D-ala-D-lactate
Dapto clinical use
Staph aureus (including MRSA), enterococcus faecalis and faecium, strep pyogenes (GAS)
Dapto major side effects
Myopathy (elevated CK)
Spectrum of polymyxins
g- (mostly aerobes - pseudomonas)
Clinical use of polymyxins
Significant toxicity with systemic use so topical; systemic use limited to serious infections
Side effects of polymyxin
Nephrotoxicity and neurotoxicity
SMX and TMP MOA
p-Aminobenzoic acid converted to dihydropteroic acid via dihydropteroate synthase (inhibited by sulfonamides); dihydropteroic acid converted to dihydrofolate via dihydrofolate reductase (inhibited by trimethoprim)
SMX/TMP clinical use
- MSSA and mild-moderate MRSA
- UTI
- respiratory tract infections (H. influenzeae, strep pneumoniae - increased resistance)
- enterocolitis (shigella)
- traveler’s diarrhea (E. coli and shigella)
- otitis media
SMX side effects
Allergies (fever, nausea, vomiting, diarrhea, rash, dermatitis, Steven Johnson syndrome); hematological disorders (megaloblastic anemia, leukopenia, granulocytopenia, thrombocytopenia, hemolytic anemia in pt with G6PD deficiency)